News

The Phase Ia, double-blind, placebo controlled study for EDP-322 announced is a single ascending dose trial in healthy volunteers. The clinical development program for EDP-322 will include the

According to the company, the new facility will be used to support ongoing research into new applications of the company’s platform technology. The new laboratory space was included

Mr Harris was most recently vice president of US sales and global marketing at Salient Surgical Technologies (formerly TissueLink). Prior to TissueLink, Mr Harris served as national sales

The Akreos AO lens is a single-piece, foldable acrylic intraocular lens with a four-haptic design and aspheric optics designed to be aberration-free. The company expects to begin shipping

The new bill was proposed by Patrick Kennedy, the representative for Rhode Island, and includes tax incentives for research into personalized medicine. Similar to Mr Obama’s 2007 bill,

The Spot-Light Her2 CISH kit has received FDA premarket approval in July 2008, as an aid in the assessment of breast cancer patients for whom trastuzumab (Herceptin) treatment

This award provides an additional $3.65 million from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), on top

Dr Hsia was formerly senior vice president of scientific affairs at Watson Pharmaceuticals before his retirement. Dr Hsia has received a PhD in industrial and physical pharmacy from

The study is a randomized, multi-center, investigator-masked, timolol- and placebo-controlled evaluation of the safety and efficacy of OT-730 in reducing the intraocular pressure in subjects with ocular hypertension